Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDillistone Regulatory News (DSG)

Share Price Information for Dillistone (DSG)

Share Price is delayed by 15 minutes
Get Live Data
10.50    -0.40 (-3.67%)
Bid:
10.00
Ask:
11.00
Spread: 1.00 (10.00%)
Market Cap: £3.72m
DSG Live PriceLast checked at - London Stock Exchange

Intraday Dillistone Share Chart

COVID-19 and Results Date Update

16 Apr 2020 07:00

RNS Number : 8060J
Dillistone Group PLC
16 April 2020
 

 

Dillistone Group Plc

COVID-19 update

and delay to announcement of final results

Dillistone Group Plc ("Dillistone", the "Company" or the "Group"), the AIM quoted supplier of software for the international recruitment industry, is today updating investors on the impact of COVID-19 on the business and the announcement of results for the year ended 31 December 2019.

COVID-19 impact

 

The Company has acted quickly to follow Government guidelines, prioritising the safety of our staff. Following on from last year's reorganisation, it had already established the ability for employees to work from home and this has been rolled out to the majority of our colleagues across the world. This is allowing the Company to continue to support its clients in their day to day working.

 

We are pleased to report that, prior to the impact of COVID-19, the Group had enjoyed a strong start to the year, with orders comfortably ahead of internal targets and early results suggesting that the Group was on track to return to profitability in H1.

 

As with other firms, the Group has seen a significant reduction in demand for our products and services over recent weeks as well as clients requesting relief on contractual terms. The Board has reacted swiftly to this, taking advantage of various government schemes, including furloughing, and it is pleased to report that all staff have given their support to the Board's plans by accepting a Group-wide temporary pay-cut, including all executive and non-executive directors.

 

While it is too early to quantify the impact of the pandemic on our full year results, it is clear that - despite our encouraging start to FY 2020 - the impact of COVID-19 will now have a material adverse effect on the Group.

 

The inherent uncertainty of the situation also means that the Company is unable to give precise guidance at this time on the likely 2020 outturn, other than that it will be significantly below any previous expectations in the market.

 

In addition to the significant cost reductions, the Board has taken steps to protect the Group's cash position. We have agreed postponement of bank loan repayments for 6 months and will also be seeking support through the UK Government's Business Interruption Loan scheme.

 

Provided such support is forthcoming, the Board does not anticipate, at this stage, seeking support from our investors. 

 

Postponement of results

As a result of the currently challenging operating environment and the request by the Financial Reporting Council to delay the announcement of preliminary results, Dillistone will be postponing the publication of its annual results for the period ended 31 December 2019, previously due to be released w/c 27 April 2020. A further update will be made in due course regarding the revised publication dates for both the annual results and Annual General Meeting.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Enquiries:

 

Dillistone Group Plc

 

 

Giles Fearnley

Chairman

Via Walbrook PR

Jason Starr

Chief Executive

 

Julie Pomeroy

Finance Director

 

 

 

 

WH Ireland Limited (Nominated adviser)

 

 

Chris Fielding

Head of Corporate Finance

020 7220 1650

 

 

 

Walbrook PR

 

 

Tom Cooper / Paul Vann

 

020 7933 8780

 

 

0797 122 1972

 

 

tom.cooper@walbrookpr.com

 

Notes to Editors:

Dillistone Group Plc (www.dillistonegroup.com) is a leader in the supply and support of software and services to the recruitment industry. Dillistone operates through the Ikiru People brand (www.IkiruPeople.com).

The Group develops, markets and supports the FileFinder, Infinity, Midoffice, ISV and GatedTalent products.

Dillistone was admitted to AIM, a market operated by the London Stock Exchange plc, in June 2006. The Group employs around 100 people globally with offices in Basingstoke, Southampton, Frankfurt, New Jersey and Sydney.

 

 

Recently published content from across the Group includes:

Recruitment Software in Australia: https://www.voyagersoftware.com/au/recruitment-software-in-australia-what-is-the-best-recruitment-software-for-agencies/

GatedTalent offers 6 months free access to retained executive search firms : https://www.talentis.global/insights/retained-search-firms-access-gatedtalent-for-free/

How to be headhunted: https://www.talentis.global/insights/headhunters-find-a-job/

Temporary Recruitment Software: https://www.voyagersoftware.com/temporary-recruitment-agency-software/

Voyager Software Australia: https://www.voyagersoftware.com/au/

Talentis: https://www.TalentIs.Global

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDSFUFAIESSEIL
Date   Source Headline
7th May 20267:00 amRNSFinal Results & Investor Presentation
24th Apr 20267:00 amRNSNotice of Final Results & Investor Presentation
9th Mar 20262:44 pmRNSHolding(s) in Company
9th Mar 20262:44 pmRNSHolding(s) in Company
9th Mar 20262:23 pmRNSHolding(s) in Company
9th Mar 20262:23 pmRNSHolding(s) in Company
2nd Mar 20263:08 pmRNSHolding(s) in Company
25th Feb 202611:40 amRNSHolding(s) in Company
25th Feb 202610:09 amRNSHolding(s) in Company
23rd Feb 20262:28 pmRNSResult of GM & Directorate Change
11th Feb 202612:59 pmRNSHolding(s) in Company
5th Feb 202611:28 amRNSResult of Placing and Subscription
4th Feb 20264:47 pmRNSProposed Placing and Subscription
30th Sep 20257:00 amRNSInterim Results & Investor Presentation
11th Sep 20257:00 amRNSNotice of Interim Results & Investor Presentation
4th Jun 202511:50 amRNSResult of AGM
4th Jun 20257:01 amRNSAGM Statement
4th Jun 20257:00 amRNSRelated party loan
9th May 202511:32 amRNSDirectorate Declaration
8th Apr 20257:00 amRNSFinal Results & Investor Presentation
3rd Apr 20257:00 amRNSNotice of Results & Investor Presentation
5th Feb 20257:00 amRNSTrading Update & Notice of Results
4th Dec 20247:00 amRNS-ROpenAI powered Interview Simulation Platform
17th Sep 20247:00 amRNSInterim Results & Investor Presentation
11th Sep 20247:00 amRNSNotice of Results & Investor Presentation
2nd Sep 20249:45 amRNSHolding(s) in Company
29th Aug 20248:30 amRNSHolding(s) in Company
23rd Aug 20247:00 amRNSTrading update and Fund Raising
15th Jul 20247:00 amRNSChange of Adviser
12th Jun 20241:40 pmRNSResult of AGM
12th Jun 20247:00 amRNSAGM Statement
25th Apr 20247:00 amRNSFinal Results & Investor Presentation
22nd Apr 20247:00 amRNSNotice of Results & Investor Presentation
9th Apr 20247:00 amRNSBlock listing Interim Review
30th Jan 20247:00 amRNSTrading Update & Notice of Results
9th Oct 20237:00 amRNSBlock listing Interim Review
26th Sep 20237:00 amRNSInterim Results & Investor Presentations
18th Sep 20237:00 amRNSNotice of Results & Investor Presentations
13th Jun 20231:18 pmRNSResult of AGM
13th Jun 20237:00 amRNSAGM Statement
25th Apr 20237:00 amRNSFinal Results & Investor Presentation
11th Apr 20237:00 amRNSBlock listing Interim Review
30th Mar 20237:00 amRNSContract & Notice of Results
2nd Feb 20237:00 amRNSTrading Update & Notice of Results
7th Nov 20227:00 amRNSDirector Dealings
10th Oct 20227:00 amRNSBlock listing Interim Review
26th Sep 20227:01 amRNSDirectorate Changes
26th Sep 20227:00 amRNSInterim Results & Investor Presentation
20th Sep 20227:00 amRNSNotice of Results & Investor Presentation
16th Jun 20228:00 amRNSIssue of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.